Technology
Health
Biotechnology

Novelion Therapeutics

$0.695
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0151 (-2.13%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell NVLN and other stocks, options, ETFs, and crypto commission-free!

About NVLN

Novelion Therapeutics, Inc. engages in the development and commercialization of pharmaceuitical products. It focuses in providing new standards of care for individuals living with rare diseases. Read More The company was founded on February 3, 1981 and is headquartered in Vancouver, Canada.

Employees
109
Headquarters
Vancouver, British Columbia
Founded
1981
Market Cap
13.54M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
672.35K
High Today
$0.71
Low Today
$0.6501
Open Price
$0.71
Volume
95.26K
52 Week High
$4.09
52 Week Low
$0.6501

Collections

Technology
Health
Biotechnology
Therapy
Canada
North America

NVLN Earnings

-$1.49
-$0.94
-$0.40
$0.15
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.